“Afib Ablation - New Insights and Future Directions”

January 6, 2011

7:30 AM

5 Maloney Conference Room

Francis E. Marchlinski, M.D.

Professor of Medicine
Director, Cardiac Electrophysiology

University of PennsylvaniaSchool of Medicine

Target Audience

This program has been designed for cardiologists, internists, CT surgeons, clinical and basic scientists in medicine, biology, genetics, biomedical engineering, pharmacology, physiology and other specialties; PhDs and PhD candidates, cardiology and CT surgery fellows, medicine and surgery housestaff, cardiac nursing and cardiology clinical and technical support staff.

Educational Objectives

After completing this activity, participants should be able to:

  • Describe the latest treatment modalities for cardiac conditions (e.g. interventional procedures such as cardiac catheterization, cardiac biopsies, electrophysiologic studies), noninvasive cardiac procedures and clinical cardiology therapy
  • Review experimental data from the basic cardiology research labs at UPHS
  • Assess the results of clinical trials from a regional and national view
  • Assess patient care through discussing medical errors, complications and unanticipated outcomes
  • Gain practice-based learning and improvement through reviewing records, specifics and revisiting errors to gain insight without blame or derision
  • Recognize the importance of systems-based practice that explicitly depict the larger context and system of health care by stressing the importance of collaborative efforts involving physicians and ancillary staff for safety and quality improvements

Accreditation

The University of Pennsylvania School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit

The University of Pennsylvania School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For more information, please contact

Denice Susini

215.662-3140

Disclosure of Relevant Financial Relationships and Unapproved Uses of Products

It is policy at the University of Pennsylvania School of Medicine for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

The staff in the Office of CME at the University of Pennsylvania School of Medicineandthe peer reviewer(s) Zalman Agus, MD, Associate Dean for CME, have disclosed that theyhave norelevant financial relationships with any commercial interests related to the content of this educational activity.

The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

Faculty Name

Joseph R. Carver, MD

The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity.

Faculty NameName of Commercial InterestRelationship

Lee R. Goldberg, MDMedtronic / Thoratec / AlereConsultant/Speaker/Adv Comm

Irving Herling, MDAstra Zeneca / Gilead / Forest PharmSpeaker

Howard Herrmann, MDAdvanced Health Media / Endovalve, Inc. Lecturer/Founder/Partner/Owner

Gerson Lehrman Group / Guidepoint GlobalConsultant

Harvard Clinical Research InstituteConsultant

Huntsman Consulting/Leerink Swann, LLCConsultant

Mass. Medical SocietyEditorial Board Member

Michael S. Parmacek, MDPhillips Lytle, LLP / NHLBIMedical Expert/Scientific Advisor

Martin St. John Sutton, MBBSMedtronic, Inc./ GlaxoSmithKleinConsultant / Clinical Trials

Francis Marchlinski, MDBiotronikSpeaker

MedtronicSpeaker Boston Scientific Speaker

SJMSpeaker, Clinical Trials

Biosense WebsterClinical Trials

Relevant Financial Relationships: Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected

Disclosure of Unapproved Uses of Products

Presenter nameProductInvestigational and/or Off-label Use

N/A